4 Notable Analyst Calls in the Biotech Sector: Loxo Oncology (LOXO), VBL Therapeutics (VBLT), Kalvista Pharmaceuticals (KALV), Aimmune (AIMT)

Investors have been treated like rented mules by the market so far here in October.  More than 75% of the S&P 500 (including …

DBV Technologies’ Pain is Aimmune Therapeutics Inc’s (AIMT) Gain

It’s a very rewarding trading day for Aimmune Therapeutics Inc (NASDAQ:AIMT) investors with shares up over 30%, making the stock Wall Street’s bull …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts